Taliglucerase alfa

TaliGlucerase Alfa is a medication that is used to treat a type of Gaucher disease. It is a recombinant form of the enzyme glucocerase beta that is missing in people with Gaucher disease. This enzyme helps break down certain fats in the body. TaliGlucerase Alfa is given as an injection under the skin (subcutaneous injection) every two weeks. Common side effects of this medication include nausea, vomiting, abdominal pain, headache and injection site reactions.

Taliglucerase alfa, also sold under the brand name Elelyso, is a medication used to treat Type 1 Gaucher disease. Here's a breakdown of its key aspects:

• Function: It's an enzyme replacement therapy (ERT). Gaucher disease is caused by a deficiency in an enzyme called glucocerebrosidase. Taliglucerase alfa acts as a replacement for this missing enzyme.
• Mechanism of action: By providing the functional enzyme, taliglucerase alfa helps break down a specific fatty substance that accumulates in the body of people with Gaucher disease. This reduces the burden on organs like the liver and spleen, and improves blood cell counts.
• Uniqueness: It's the first FDA-approved plant-based medication produced using genetically modified carrot cells.
• Delivery: Taliglucerase alfa is administered by intravenous injection.

Important points to note:

• Taliglucerase alfa is typically used for long-term treatment.
• It's generally well-tolerated, with side effects being mostly mild or moderate.